Current study results from the report, ‘Inflammatory breast cancer: novel preoperative therapies,’ have been published. According to recent research from the United States, The treatment of inflammatory breast cancer (IBC) has been hampered by the diagnostic rarity of the disease and its consequent inclusion in clinical trials of preoperative treatment for the more indolent locally advanced breast cancer (LABC). Source: General Cancer News Articles Provided by Cancer Compass